Scientific Advisory Board

 Brian J. Balin, Ph.D.


Dr. Balin is the Director of the Center for Chronic Disorders of Aging – Basic Science at the Philadelphia College of Osteopathic Medicine.  He is the Chair of the Department of Bio-Medical Sciences and Professor of Neuroscience and Neuropathology. 

Dr. Balin teaches in both the DO and Biomedical masters programs. He lectures and participates in case presentations and laboratory sessions on a variety of subjects including: neuroscience, neuroanatomy, neurodegeneration, neuropathology, general pathology, molecular basis of cancer, and infectious disease.

Dr. Balin is an internationally-recognized expert in the field of Alzheimer’s Disease research. He is highly published in peer-reviewed journals, and has written a number of chapters and reviews on the pathology of Alzheimer’s disease, including reviews on the “Pathogen Hypothesis” of this disease (see live discussion section, In addition, he has presented and continues to present his work at major national and international scientific meetings including a number of international and world congresses on Alzheimer’s disease and related dementias.

Dr. David L. Hahn, MD, MS


Dr. Hahn is a family physician with advanced research training in epidemiology, medical microbiology & immunology, and clinical trial design. Dr. Hahn has been performing primary care practice-based research (PBR) into infectious causes for asthma since the late 1980s. Primary care PBR is research done in partnership with practicing clinicians in communities and the patients they serve to address problems that most patients have, most of the time.

Asthma is a common condition in people of all ages. Experts agree that “the root cause for asthma is inflammation” and that “there is no cure for asthma.” Current treatments are palliative, not curative (i.e., they suppress or “control” asthma symptoms only as long as they are taken).

Dr. Hahn has published over 50 peer reviewed articles, book chapters, invited commentaries and correspondence challenging current expert opinion by proposing the “infectious asthma (IA)” hypothesis: some asthma (the most severe type) is causally associated with chronic lung infections (such as Chlamydia pneumoniae and Mycoplasma pneumoniae) that are treatable with appropriate courses of certain antibiotics. The IA hypothesis opens the door for further research into asthma treatment, cure and even prevention.

Dr. Charles W. Stratton, MD


Dr. Stratton is an Associate Professor of Pathology and Medicine, and Director of a Clinical Microbiology Laboratory.  He is Board Certified in Internal Medicine, Infectious Diseases and Medical Microbiology.

Emerging infectious diseases are a recognized problem in clinical medicine. Chlamydia pneumoniae was first recognized in 1988 as a cause of community acquired respiratory tract infections. Since then, this unique pathogen has been associated with a number of chronic diseases, including atherosclerosis and asthma. The pathogenesis of Chlamydia pneumoniae and its role in chronic inflammatory diseases as a cause of secondary infection worsening the original inflammatory process is the basis of current research efforts.

Dr. Stratton’s primary research is in pharmacodynamics, particularly the mechanisms of resistance. He has authored or co-authored over 200 papers on this subject and is recognized as an international authority in this area. Dr. Stratton has served on a number of editorial boards. Dr. Stratton is a retired Colonel in the U.S. Army Reserves. He received the Bronze Star for service in the Persian Gulf War.

He is a member of numerous professional organizations, and is a fellow in the American College of Physicians, College of American Pathologists, American Society of Clinical Pathologists, American Academy of Microbiology, and Infectious Diseases Society of America. For 14 years, he served as editor of “Topics in Clinical Microbiology”, a bimonthly section of Infection Control and Hospital Epidemiology.

Dr. Stratton also served as editor for Infectious Diseases Newsletter and the Antimicrobics and Infectious Diseases Newsletter. Dr. Stratton is the author of many articles, research publications, review publications, chapters, and abstracts. He has lectured extensively at teaching activities, meetings and conferences.

Wilmore Webley, Ph.D.


Dr. Webley is an Associate Professor of Microbiology and the Director of PreMed/PreHealth Advising at the University of Massachusetts Amherst. Webley completed his undergraduate degree in Medical Technology at Northern Caribbean University, Mandeville JA. He earned a MS degree and later the Ph.D. in Microbiology at UMass Amherst with expertise in immunology, pathogenic bacteriology, and host-pathogen interactions.

Dr. Webley is a Fulbright Scholar, a recipient of the Distinguished Teaching Award in recognition for outstanding teaching accomplishments. Dr. Webley serves on the editorial boards of the International Journal of Vaccines and Immunization, the Journal of Medical Microbiology & Diagnosis, Vaccines and Microbiology & Experimentation. He is a member of the International Society for Vaccines, American Society for Microbiology and the Chlamydia Basic Research Society.

His research focuses on infectious disease mechanisms and the role of specific infections in chronic diseases. Specifically, the Webley Lab has pioneered work in Chlamydia vaccine development and the role of pathogenic microbes in asthma initiation and exacerbation. The Webley Lab uses immunoinformatics and gas vesicle nanoparticles of Halobacteria as a platform for multi-subunit antigen display and have confirmed that this system is a potentially effective display and delivery platform for antigens of chlamydial vaccine antigens. His laboratory was the first to culture Chlamydia from bronchoalveolar lavage samples taken from pediatric patients with chronic, severe asthma and has since shown that early life chlamydial infection increases the risk for asthma onset and results in a unique asthma phenotype. His recent work has demonstrated the efficacy of antibiotics in treating a subset of severe asthmatics. His published work has made significant contributions to the fields of microbiology, vaccinology, allergy and immunology.